Insulin resistance and hypertension in the absence of subcutaneous fat.
When a patient presents with insulin resistance, a red flag for cardiovascular risk appears. What is the contribution of visceral fat to this syndrome? What are the risks and benefits of the treatment options for the coexistent cardiovascular risk factors?
Chaudhuri
A
A
State University of New York at Buffalo, USA.
Izzo
J L
JL
D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D001824:Body Constitution; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000150:complications*; D009765:Obesity / Q000150:complications* / Q000378:metabolism